CSL Limited (CMXHF) Financials
CMXHF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 33.6 billion | 17.3 billion |
| Dec. 31, 2025 | 37.9 billion | 17.5 billion |
| June 30, 2025 | 39.5 billion | 18.1 billion |
| Dec. 31, 2024 | 38.4 billion | 17.9 billion |
CMXHF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 1.8 billion | ? |
| Dec. 31, 2025 | 1.0 billion | ? |
| June 30, 2025 | 2.2 billion | 79.0 million |
| Dec. 31, 2024 | 881.0 million | ? |
CMXHF Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | -2.9 billion |
| Dec. 31, 2025 | 408.3 million |
| June 30, 2025 | 1.0 billion |
| Dec. 31, 2024 | 1.9 billion |
CMXHF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.5 billion | 8.4 billion | 1.4 billion |
| Dec. 31, 2025 | 1.1 billion | 10.4 billion | 1.4 billion |
| June 30, 2025 | 2.2 billion | 9.2 billion | 1.7 billion |
| Dec. 31, 2024 | 1.5 billion | 7.8 billion | 1.6 billion |
CMXHF Shares Outstanding
CMXHF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 323.6 million | 613.5 million | 1.1 billion | - |
| Dec. 31, 2025 | 301.4 million | 611.0 million | 1.0 billion | - |
| June 30, 2025 | 283.2 million | 739.1 million | 1.2 billion | 872.0 million |
| Dec. 31, 2024 | 378.0 million | 646.0 million | 1.2 billion | 744.0 million |
CMXHF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 7.3 billion | 4.1 billion |
| Dec. 31, 2025 | 8.4 billion | 4.2 billion |
| June 30, 2025 | 7.3 billion | 3.9 billion |
| Dec. 31, 2024 | 8.2 billion | 3.9 billion |
CMXHF
Price: $126.18
Dividend Yield: 2.30%
Forward Dividend Yield: 5.14%
Payout Ratio: 43.59%
Dividend Per Share: 6.48 USD
Earnings Per Share: 6.17 USD
P/E Ratio: 17.20
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Market Capitalization: 60.7 billion
Average Dividend Frequency: 3
Years Paying Dividends: 33
DGR3: 30.00%
DGR5: 26.52%
DGR10: 15.30%
DGR20: 18.06%